Journal profile · Medicine, General & Internal
LANCET
ISSN 0140-6736 · eISSN 1474-547X · Elsevier Ltd · ENGLAND · Weekly · Founded 1823
LANCET: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 105.5; hybrid open access; APC about USD 7,890; median 47 days to acceptance (103 articles, last 24 months); community-reported acceptance: about 50%; 1,484 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
LANCET is published by Elsevier Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Human auditory perception and evaluation, Diverse Scientific and Economic Studies and Earthquake and Disaster Impact Studies, together about 26.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
From the journal's Aims & Scope
Research area (LetPub): Medicine, General & Internal
Main research topics OpenAlex counts of recent articles; shares are approximate
- Human auditory perception and evaluationEngineering10.4%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance8.3%
- Earthquake and Disaster Impact StudiesSocial Sciences7.6%
- Primary Care and Health OutcomesHealth Professions5.2%
- Medical History and InnovationsArts and Humanities5.1%
- Healthcare Policy and ManagementEconomics, Econometrics and Finance5.1%
- History of Medical PracticeMedicine5.1%
- Educational Leadership and PracticesSocial Sciences4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, General & Internal | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, General & Internal | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, General & Internal | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 105.5LetPub ·
- Impact factor (publisher)
- 109Publisher website ·
- CiteScore 2026-06
- 92.4LetPub ·
- CiteScore (publisher)
- 92.4Publisher website ·
- SJR 2026-06
- 14.82LetPub ·
- SNIP 2026-06
- 27.7LetPub ·
- h-index
- 700LetPub ·
- h-index
- 1,215OpenAlex ·
- i10-index
- 70,727OpenAlex ·
- 2-year mean citedness
- 20.96OpenAlex ·
- Self-citation rate
- 1.3%LetPub ·
- Share of gold OA articles
- 25.49%LetPub ·
Volume
- Articles per year
- 244LetPub ·
Articles by year OpenAlex count · 476,080 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,128 | 166 | 2,298 |
| 2025 | 1,484 | 528 | 23,477 |
| 2024 | 1,707 | 572 | 64,745 |
| 2023 | 1,560 | 866 | 69,202 |
| 2022 | 1,446 | 723 | 110,446 |
| 2021 | 1,638 | 1,072 | 181,311 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
47 daysMedian, submission to acceptance · P25–P75 12 days – 97 days
- Acceptance to online
- median 50 days (64 articles)
- Submission to online
- median 89 days
- Sample
- 103 articles with submission and acceptance dates (2,740 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- First decision after review
- 35 daysPublisher website ·
- Submission to acceptance
- 28 daysPublisher website ·
- Acceptance to publication
- 58 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 7,890 / EUR 7,380 / GBP 6,320 / JPY 978,600 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Weekly
- Founded
- 1823
- ISSN
- 0140-6736
- Electronic ISSN
- 1474-547X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about LANCET
What CAS zone is LANCET in?
In the 2025 upgraded edition of the CAS Journal Ranking, LANCET is in Zone 1 of Medicine, and in Zone 1 of the minor category Medicine, General & Internal; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of LANCET?
The latest impact factor listed by LetPub is 105.5; CiteScore 92.4, h-index 1215.
How long does peer review take at LANCET?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 47 days (interquartile range 12–97 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index LANCET?
According to LetPub and DOAJ records, LANCET is indexed in SCIE and Scopus.
Is LANCET open access, and what is the APC?
LANCET is a hybrid journal. For open-access publication: APC about USD 7,890.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .